RGEN Stock Analysis: Buy, Sell, or Hold?
RGEN - Repligen Corp
$142.40
3.41 (2.45%)
▲
5d:
-1.95%
30d:
+17.56%
90d:
+20.35%
BUY
MODERATE Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 04, 2026
Get Alerted When RGEN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: RGEN shows positive signals but monitor for confirmation. Market pricing in 1.7% decline. Moderate conviction.
💡 BUY OPPORTUNITY: RGEN shows positive signals but monitor for confirmation. Market pricing in 1.7% decline. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$124.03
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$77.01
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: RGEN is currently trading at $142.40, which is considered extended relative to its 30-day fair value range of $118.98 to $136.19. The stock's valuation (Forward PE: 55.9) is in line with its historical norms (58.9). Remarkably, the market is currently pricing in an annual earnings decline of 1.7% over the next few years. This pessimistic expectation contrasts with the company's recent 47.9% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, RGEN is in a strong downtrend. The price is approaching resistance at $132.25. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: RGEN has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $176.11 (+23.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, RGEN is in a strong downtrend. The price is approaching resistance at $132.25. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: RGEN has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $176.11 (+23.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$118.98 -
$136.19
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
61.9%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 23.7% below Wall St target ($176.11)
Trading Range Analysis
30-Day Trading Range
$118.98 -
$136.19
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$112.00
Resistance Level
$132.25
Current Trend
Strong Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
55.90
Wall Street Target
$176.11
(+23.7%)
Revenue Growth (YoY)
14.8%
Earnings Growth (YoY)
47.9%
Profit Margin
6.7%
Valuation Discount vs History
-1.7% cheaper
PE vs Historical
55.9 vs 58.9
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-1.7%
(market-implied from PE analysis)
1-Year Target
$139.98
(-2%)
2-Year Target
$137.60
(-3%)
3-Year Target
$135.26
(-5%)
3-Yr Target (if PE normalizes)
(PE: 56→59)
$142.53
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 55.9, Growth: 27.2%)
$293.30
(+106%)
Base:
(SPY PE: 21.8, Growth: 27.2%)
$114.29
(-20%)
Bear:
(PE: 18.5, Growth: 27.2%)
$97.14
(-32%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (69x PE), but valuation improves significantly next year (56x PE) as earnings recover.
Forward PE: 68.97 | Forward EPS (Implied): $2.06
Bull Case
$171.95
(+21%)
Analyst growth 15.0%, PE expands to 72.4
Base Case
$142.40
(0%)
Market implied 0.0%, PE stable at 69.0
Bear Case
$108.94
(-24%)
Severe decline -15.0%, PE contracts to 62.1
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 55.9 to 58.9
Stabilization Target:
$150.05
(+5.4%)
PE Expansion Potential:
+5.4%
Share & Embed Analysis
Last updated: July 03, 2026 5:13 PM ET
Data refreshes hourly during market hours. Next update: 6:13 PM
Data refreshes hourly during market hours. Next update: 6:13 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is RGEN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$565 | 65 BUY |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$88 | 60 HOLD |
|
RMD
ResMed Inc |
BUY
19 analysts |
$261 | 67 BUY |
|
WST
West Pharmaceutical Serv… |
STRONG BUY
13 analysts |
$359 | 64 BUY |
|
ALGN
Align Technology Inc |
BUY
18 analysts |
$209 | 60 HOLD |
